Intracerebral Burkitt's lymphoma: pathology, clinical features and treatment.
D000293:Adolescent; D000493:Allopurinol / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D002051:Burkitt Lymphoma / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010211:Papilledema / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D000493:Allopurinol; D003907:Dexamethasone; D003520:Cyclophosphamide; D011239:Prednisolone; D006918:Hydroxyurea; D008727:Methotrexate; D003630:Daunorubicin